MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biomaterials (Adhesives, Sealants and Glues)
Lifebond
Attachments
Lifebond
Parents
*Architects: Biomaterials (Adhesives, Sealants and Glues)
*Architects: Blood Processing, Blood Pumps, Diagnostics, Hemorrhage, Bleeding, Hemostatis, Transfusion, Intravenous (IV) Management
*Architects: Regenerative Medicine
*Industry: Israel
Venture Capital: Series C
Children
Giza Venture Capital and aurum Ventures co-led the round, and were joined by return backers Glenrock Israel, Pitango Venture Capital and Zitelman Group.
Raised $20 million in new VC funding (2011)
Surgeons need the surgical toolbox of tomorrow to meet the medical needs of today.
They need easy-to-use biosurgical products and reliable biomaterial technology. LifeBond's next-generation surgical sealants and absorbable hemostats will fill the biosurgical tool market gap.
Tissue sealing, rapid hemostasis, wound healing, tissue regeneration: these and other increasingly complex clinical challenges are not being met by current therapeutic solutions.